Article Information
History
- April 20, 2020.
Article Versions
- Version 1 (March 20, 2020 - 07:21).
- Version 2 (April 15, 2020 - 08:54).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mengyuan Li1,2,
- Zhilan Zhang1,2,
- Shanmei Jiang1,2,
- Qian Liu1,2,
- Canping Chen1,2,
- Yue Zhang3,4,5 and
- Xiaosheng Wang1,2,*
- 1Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China
- 2Big Data Research Institute, China Pharmaceutical University, Nanjing 211198, China
- 3Pinghu hospital of Shenzhen university, Shenzhen 440307, China
- 4Futian Hospital for Rheumatic Diseases, Shenzhen 518000, China
- 5Department of Rheumatology and Immunology, The First Clinical college of Harbin Medical University, Harbin 150001, China
- ↵*Correspondence to: Xiaosheng Wang, E-mail: xiaosheng.wang{at}cpu.edu.cn
Posted April 20, 2020.
Predicting the epidemic trend of COVID-19 in China and across the world using the machine learning approach
